Abstract
An 18-year-old woman presented with galactorrhea and was thought to have a prolactinoma. As acromegaly signs and symptoms progressed, she proved to have an elevated GH nadir on oral glucose tolerance test but IGF1 was initially normal. The disease progressed and IGF-1 became elevated over time. She required two pituitary surgeries and radiation in addition to medical therapies for acromegaly. The case of discrepancy between IGF1 and GH levels is discussed as well as the management strategy for aggressive cases of acromegaly in which disease persists after pituitary surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Melmed S. Acromegaly. N Engl J Med. 2006;355:2558–73.
Freda PU. Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin Endocrinol (Oxf). 2009;71:166–70.
Frystyk J, Freda P, Clemmons DR. The current status of IGF-I assays—a 2009 update. Growth Horm IGF Res. 2010;20:8–18.
Freda PU. Current concepts in the biochemical assessment of the patient with acromegaly. Growth Horm IGF Res. 2003;13:171–84.
Cazabat L, et al. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. Eur J Endocrinol. 2007;157:1–8.
Katznelson L, et al. Acromegaly: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014;99:3933–51.
Fleseriu M, et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:3888–921.
Dineen R, Stewart PM, Sherlock M. Acromegaly. QJM. 2017;110(7):411–20. pii: hcw00.
Abs R, et al. Cabergoline in the treatment of acromegaly: a study in 64 patients. J Clin Endocrinol Metab. 1998;83:374–8.
Chang SC, Chen CH, Lu ML. Cabergoline-induced psychotic exacerbation in schizophrenic patients. Gen Hosp Psychiatry. 2008;30:378–80.
Barake M, et al. Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study. Pituitary. 2014;17:150–6.
Shih HA, Loeffler JS. Radiation therapy in acromegaly. Rev Endocr Metab Disord. 2008;9:59–65.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Nachtigall, L.B. (2018). Acromegaly: Diagnosis and Management in Patients Who Present with Discrepancy Between IGF-1 and GH. In: Nachtigall, L. (eds) Pituitary Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-90909-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-90909-7_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90907-3
Online ISBN: 978-3-319-90909-7
eBook Packages: MedicineMedicine (R0)